Showing results (441-450 of 573) with videos related to

Sort By:
Pageof 58
Nature Medicine|July 27, 2023
Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim resultsRaffit Hassan, Marcus Butler, Roisin E O'Cearbhaill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2009
Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumorsRoy S Herbst, David Hong, Linnea Chap, et al.
Targeted Oncology|December 2, 2022
Phase I Study Evaluating Glesatinib (MGCD265), An Inhibitor of MET and AXL, in Patients with Non-small Cell Lung Cancer and Other Advanced Solid TumorsChristian Kollmannsberger, Herbert Hurwitz, Lyudmila Bazhenova, et al.
AJNR. American Journal of Neuroradiology|February 20, 2026
Large Language Models for Accurate Medical Chart Abstraction: Enabling Scalable and Secure AI Deployment in StrokeZhusi Zhong, Carl M Porto, David Hong, et al.
The American Journal of Cardiology|February 16, 2019
Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint InhibitorsNicolas Palaskas, Jacob Morgan, Tina Daigle, et al.
Oncoimmunology|May 22, 2025
Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad ConferenceFereshteh Talebi, Fabiana Gregucci, Jalal Ahmed, et al.
JCO Precision Oncology|January 5, 2023
HRAS Mutations Define a Distinct Subgroup in Head and Neck Squamous Cell CarcinomaNiamh Coleman, Kathrina L Marcelo, Julia F Hopkins, et al.
The International Journal of Cardiovascular Imaging|June 14, 2024
Intravascular imaging-guided percutaneous coronary intervention for heavily calcified coronary lesions: a systematic review and meta-analysisDoosup Shin, David Hong, Mandeep Singh, et al.
Pageof 58